Henley Business School South Africa

Cameco Announces Third Quarter Results; Tier-One Transition Continues to Drive Gross Profit Improvement; Amplified Security of Supply Concerns Benefit Full-Year Revenue Outlook; Decade-High Industry Contracting Volume Achieved; Dividend Declared

Retrieved on: 
星期二, 十月 31, 2023
Chemicals, Plastics, Mining, Minerals, Manufacturing, Energy, Natural Resources, Nuclear, Caspian, Transfer, JV, Canada Revenue Agency, United Kingdom, Brookfield Renewable Partners, NYSE, International, Health, Uranium, WNA, Government, Canadian Nuclear Safety Commission, University, CCO, Acquisition, International Financial Reporting Standards, Babcock International, MBA, Urenco Group, Nuclear energy, Engineering, Institution of Chemical Engineers, International Atomic Energy Agency, Environment, Growth, World Nuclear Association, Transport, Risk, Turkish coup d'état, Tax court, Henley Business School, Safety, McArthur, Chief commercial officer, CRA, Henley Business School South Africa, TSX, Renewable energy, Uranium mining, Bank, Rare-earth element, Westinghouse, Kazatomprom, Cameco, McArthur River, Energoatom, Inkai Uranium Project

In the short term, supply chain issues and inflation risks are causing production challenges for current operators.

Key Points: 
  • In the short term, supply chain issues and inflation risks are causing production challenges for current operators.
  • Compared to previous price cycles, the market does not have the inventory or secondary supplies to absorb market shocks.
  • This conference of government and industry leaders met with the intention of building leadership and cooperation in nuclear energy.
  • The transition to a clean and secure energy world is our imperative and I look forward to helping this transition with Cameco,” said Dominic Kieran.

Wilson Language Training (“Wilson”) Appoints Chief People Officer and Chief Financial Officer to Join Leadership Team

Retrieved on: 
星期四, 三月 2, 2023
Primary, Secondary, Preschool, Education, Consumer, Teens, Children, Other Education, LaRue, CHRO, INSEAD, Wilson, Blackboard, Staples, Vista Equity Partners, Sale, Learning, Henley Business School South Africa, Accounting, Providence Equity, Senior, Growth, United Kingdom, CFO, Management, Finance, Clarabridge

Wilson Language Training is pleased to announce the appointment of Ewan McCulloch as Chief People Officer, and Mario LaRue as Chief Financial Officer beginning March 1, 2023.

Key Points: 
  • Wilson Language Training is pleased to announce the appointment of Ewan McCulloch as Chief People Officer, and Mario LaRue as Chief Financial Officer beginning March 1, 2023.
  • McCulloch brings with him a wealth of expertise developed during his international career in human resources and general management leadership roles, most recently at The Cengage Group and Staples.
  • He has experience in publicly traded and private equity backed businesses across a range of sectors including banking and finance, retail, energy, and education technology.
  • As CFO, he will lead Wilson’s financial activities including accounting and controllership, financial planning and analysis, tax, investor relations, internal audit, and treasury.

Asante Gold Announces Appointment of Executive Vice President & Country Director

Retrieved on: 
星期四, 三月 31, 2022
Country, LEI, Henley Business School, CEO, Technical Report Archive & Image Library, Gold, Intention, Resource management, Mineral resource estimation, GLOBE, Bibiani, Commerce, Sustainability, Master of Business Administration, Competent person, Regulation and licensure in engineering, CSE, Honours degree, IIROC, Executive, Ghana Chamber of Mines, Frankfurt Stock Exchange, Henley Business School South Africa, SEDAR, AngloGold Ashanti, Electrical engineering, JORC, Technical report, Industry, Business administration, Canadian Securities Exchange, Forward-looking statement, Growth, Mining, Satellite, PEF, CP, Company, Kwame Nkrumah University, Person, First, News, Nature, Management, Asante, Technology

VANCOUVER, British Columbia, March 31, 2022 (GLOBE NEWSWIRE) -- Asante Gold Corporation (CSE:ASE | FRANKFURT:1A9 | U.S.OTC:ASGOF) (Asante or the Company) is pleased to announce the appointment of Frederick Attakumah as Executive Vice President and Country Director with effect from April 1, 2022.

Key Points: 
  • VANCOUVER, British Columbia, March 31, 2022 (GLOBE NEWSWIRE) -- Asante Gold Corporation (CSE:ASE | FRANKFURT:1A9 | U.S.OTC:ASGOF) (Asante or the Company) is pleased to announce the appointment of Frederick Attakumah as Executive Vice President and Country Director with effect from April 1, 2022.
  • Prior to joining Asante, Mr. Attakumah was the Executive Vice President and Managing Director of Asanko Gold Ghana Limited.
  • He has also held several senior executive roles including Managing Director of AngloGold Ashanti (Ghana) Limited and Vice President of Sustainability for AngloGold Ashantis operations in Ghana.
  • Commenting on the appointment, Dave Anthony, CEO of Asante stated, We are delighted to welcome Frederick as Executive Vice President and Country Director of Asante.

Bolt Biotherapeutics Announces Changes to its Board of Directors

Retrieved on: 
星期五, 十一月 19, 2021
Senior, NSCLC, Trastuzumab, Bristol Myers Squibb, Bolt, Lead, CEA, GLOBE, Biotechnology, Board of directors, Board, University, Forma, Immune stimulating antibody conjugate, CEO, PD-L1, Marketing, Cancer, Breast cancer, HER2, Shire (pharmaceutical company), Henley Business School South Africa, Forward-looking statement, Degenerative disease, Pfizer, IPO, Therapy, Northwest Biotherapeutics, Henley Business School, Chemical engineering, The Marketing Institute of Ireland, Merck Serono, ISAC, Patient, Genentech, Safety, Eli Lilly, Industry, Australian Marketing Institute, Novartis, SEC, Leadership, Business, Janssen, Nasdaq, Antibody, Myelocyte, Vanderbilt University, B.E, Doctor of Philosophy, NPS, Pharmaceutical industry, Vaccine

We are eager to benefit from his knowledge as we make patient-focused decisions to expand our pipeline, said Randall Schatzman, Ph.D., CEO of Bolt Biotherapeutics.

Key Points: 
  • We are eager to benefit from his knowledge as we make patient-focused decisions to expand our pipeline, said Randall Schatzman, Ph.D., CEO of Bolt Biotherapeutics.
  • Mr. OCallaghan also serves on the board of several privately held biotechnology companies, including Indaptus Therapeutics, Aquavit Therapeutics and Biocom Purchasing Group.
  • Bolt has formed a robust pipeline of immune-stimulating, myeloid-engaging therapeutics with the goal of offering long-term tumor remissions for patients.
  • I am excited to help the Bolt Biotherapeutics drive patient-focused decisions that could advance and grow the companys pipeline of product candidates.